Results 51 to 60 of about 34,631,452 (311)

Prevalence of 21 Physician‐Defined Severe Toxicities Following Childhood Acute Lymphoblastic Leukemia Treatment: Australian Retrospective Cohort Study

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Acute lymphoblastic leukemia (ALL) is the most common pediatric cancer, with an overall survival now surpassing 90% in developed countries. However, treatments are not without adverse effects. In this study, we apply the severe toxicity‐free survival (STFS) framework to determine the prevalence of 21 physician‐defined severe ...
Lane Collier   +10 more
wiley   +1 more source

Read-Based Phasing and Analysis of Phased Variants with WhatsHap

open access: yes, 2022
AbstractWhatsHap is a command-line tool for phasing and phasing-related tasks. It allows to infer haplotypes in diploid and polyploid samples based on (preferably long) reads covering at least two heterozygous variants. It offers additional tools for working with phased variant calls such as computing statistics, comparing different phasings and ...
Martin M, Ebert P, Marschall T
openaire   +3 more sources

Accuracy in Rietveld quantitative phase analysis: a comparative study of strictly monochromatic Mo and Cu radiations

open access: yesJournal of Applied Crystallography, 2016
This work focuses on the comparison of Mo Kα1 and Cu Kα1 radiations for the Rietveld quantitative phase analysis of challenging crystalline mixtures including amorphous content determination. The quantifications have been carried out by using calibration
L. León-Reina   +6 more
semanticscholar   +1 more source

Sustained Therapeutic Efficacy of Intravenous Plasminogen Concentrate in Pediatric Patients With Type 1 Plasminogen Deficiency: An Analysis of Dosing Parameters and Clinical Outcomes

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Type 1 plasminogen deficiency (PLGD‐1) is an ultra‐rare autosomal recessive disorder caused by variants in the PLG gene and affects approximately 1.6 individuals per million. The condition is characterized by decreased plasminogen levels and impaired function, resulting in fibrin‐rich lesions on mucous membranes throughout the body.
Charles Nakar   +7 more
wiley   +1 more source

An analysis of phase transition models

open access: yesEuropean Journal of Applied Mathematics, 1996
We consider phase transition processes in which the thermodynamic variables are the temperature and an order parameter. Various classes are identified and many specific examples are illustrated. In this framework the question of the range of applicability of the so-called ‘additivity rules’ is investigated, showing that they apply only to a very ...
FASANO, ANTONIO, PRIMICERIO, MARIO
openaire   +3 more sources

Persistent homology analysis of phase transitions [PDF]

open access: yesPhysical Review E, 2016
10 pages; 10 ...
Donato, Irene   +6 more
openaire   +8 more sources

Guidelines for Pediatric Radiotherapy Simulation: A Report From the Children's Oncology Group Radiation Oncology Discipline

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric radiation therapy presents unique challenges compared to adult treatments, including those of immobilization, potential need for sedation, and the critical importance of accurate, reproducible positioning. Additionally, heightened attention to imaging doses is necessary to minimize long‐term toxicity in survivors.
Parham Alaei   +17 more
wiley   +1 more source

Recurrence plots for the analysis of complex systems [PDF]

open access: yes
Recurrence is a fundamental property of dynamical systems, which can be exploited to characterise the system’s behaviour in phase space.A powerful tool for their visualisation and analysis called recurrence plotwas introduced in the late 1980’s.
N. Marwan   +3 more
semanticscholar   +1 more source

Personalized Zebrafish Models for Fusion‐Positive Pediatric Sarcomas

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Clinical sequencing efforts have revolutionized our approaches to categorizing pediatric cancers in real time. This has dramatically improved our ability to profile pediatric tumors, identify actionable vulnerabilities, and influence clinical care.
Lisa H. Hall   +2 more
wiley   +1 more source

Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials

open access: yesThe Lancet Oncology, 2019
Summary Background Entrectinib is a potent inhibitor of tropomyosin receptor kinase (TRK) A, B, and C, which has been shown to have anti-tumour activity against NTRK gene fusion-positive solid tumours, including CNS activity due to its ability to ...
R. Doebele   +37 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy